Barclays lowered the firm’s price target on Chemours to $21 from $22 and keeps an Equal Weight rating on the shares. The firm says interest rate cuts, China stimulus, and tariff implementation has boosted 2025 sentiment on U.S. chemicals, “but it’s not showing up in the numbers quite yet.” Continued China net export growth remains worrisome, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CC:
- Woodward names Ron Charles as Chief Human Resources Officer
- Woodward names Ron Charles as Chief Human Resources Officer Chemours
- Chemours announces development of low GWP retrofit approach for vehicles
- Chemours Company Enhances Investor Relations with New Presentation
- Chemours price target lowered to $30 from $35 at BMO Capital